SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kristiina Cajanus, Emil J. Holmström, Maija Wessman, Verneri Anttila, Mari A. Kaunisto, Eija Kalso, Effect of endocannabinoid degradation on pain, PAIN, 2016, 157, 2, 361

    CrossRef

  2. 2
    Brian J Anderson, Jacqueline A Hannam, Considerations when using pharmacokinetic/pharmacodynamic modeling to determine the effectiveness of simple analgesics in children, Expert Opinion on Drug Metabolism & Toxicology, 2015, 11, 9, 1393

    CrossRef

  3. 3
    Gisèle Pickering, Antiepileptics for Post-Herpetic Neuralgia in the Elderly: Current and Future Prospects, Drugs & Aging, 2014, 31, 9, 653

    CrossRef

  4. 4
    Gillian Lauder, Anthony Emmott, Confronting the challenges of effective pain management in children following tonsillectomy, International Journal of Pediatric Otorhinolaryngology, 2014, 78, 11, 1813

    CrossRef

  5. 5
    Kinga Sałat, Paula Kowalczyk, Beata Gryzło, Anna Jakubowska, Katarzyna Kulig, New investigational drugs for the treatment of neuropathic pain, Expert Opinion on Investigational Drugs, 2014, 23, 8, 1093

    CrossRef

  6. 6
    Sherry Shu-Jung Hu, Yu-Cheng Ho, Lih-Chu Chiou, No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids, European Journal of Neuroscience, 2014, 39, 3
  7. You have free access to this content7
    J Sousa-Valente, A P Andreou, L Urban, I Nagy, Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics, British Journal of Pharmacology, 2014, 171, 10
  8. 8
    Brian J Anderson, John Anker, Why is there no morphine concentration–response curve for acute pain?, Pediatric Anesthesia, 2014, 24, 3
  9. 9
    G.J. Brenner, R.S. Griffin, Encyclopedia of the Neurological Sciences, 2014,

    CrossRef

  10. You have free access to this content10
    Bruno Georg Oertel, Jörn Lötsch, Clinical pharmacology of analgesics assessed with human experimental pain models: bridging basic and clinical research, British Journal of Pharmacology, 2013, 168, 3
  11. 11
    Elise M. Weerts, Mary E. McCaul, Hiroto Kuwabara, Xiaoju Yang, Xiaoqiang Xu, Robert F. Dannals, J. James Frost, Dean F. Wong, Gary S. Wand, Influence of OPRM1 Asn40Asp variant (A118G) on [11C]carfentanil binding potential: preliminary findings in human subjects, The International Journal of Neuropsychopharmacology, 2013, 16, 01, 47

    CrossRef

  12. 12
    Xavier Borrat, Iñaki F. Trocóniz, José F. Valencia, Silvia Rivadulla, Oriol Sendino, Josep Llach, Jenifer Muñoz, Sergi Castellví-Bel, Mathieu Jospin, Erik W. Jensen, Antoni Castells, Pedro L. Gambús, Modeling the Influence of the A118G Polymorphism in the OPRM1 Gene and of Noxious Stimulation on the Synergistic Relation between Propofol and Remifentanil, Anesthesiology, 2013, 118, 6, 1395

    CrossRef

  13. 13
    Aline Hajj, Lydia Khabbaz, Jean-Louis Laplanche, Katell Peoc’h, Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg, Pharmacogenomics, 2013, 14, 5, 575

    CrossRef

  14. 14
    S. J. Kang, M. Rangaswamy, N. Manz, J.-C. Wang, L. Wetherill, T. Hinrichs, L. Almasy, A. Brooks, D. B. Chorlian, D. Dick, V. Hesselbrock, J. Kramer, S. Kuperman, J. Nurnberger, J. Rice, M. Schuckit, J. Tischfield, L. J. Bierut, H. J. Edenberg, A. Goate, T. Foroud, B. Porjesz, Family-based genome-wide association study of frontal theta oscillations identifies potassium channel gene KCNJ6, Genes, Brain and Behavior, 2012, 11, 6
  15. 15
    R. Landau, L. A. Bollag, J. C. Kraft, Pharmacogenetics and anaesthesia: the value of genetic profiling, Anaesthesia, 2012, 67, 2
  16. 16
    Tsippora Shainhouse, Ernest Lee, Howard I. Maibach, Dermatotoxicology, 2012,

    CrossRef

  17. 17
    James Zacny, Ask the Experts: What do we know (and not know) about prescription opioid misuse in the context of chronic pain management?, Pain Management, 2011, 1, 5, 395

    CrossRef

  18. 18
    Cholawat Pacharinsak, Alvin J. Beitz, Mechanisms of Cancer Pain,